USAN - NEUROSURGICAL CRITICAL CARE UNIT
USAN nas redes sociais
  • HR contra a SEPSE
    • QUEM SOMOS
  • NOTICIAS USAN
  • TUTORIAIS
    • IMAGENS
    • PROTOCOLOS DO SERVIÇO
    • PRODUÇÃO CIENTÍFICA
    • TEMAS USAN
  • ENFERMAGEM
  • NEUROCIRURGIA
  • SENUT HR
  • FISIOTERAPIA
  • FONOTERAPIA
    • SAÚDE ORAL EM UTI
  • CONTATO

SUPORTE CLINICO PARA PACIENTES COM SUSPEITA DE MORTE ENCEFÁLICA (ME)

1/29/2012

1 Comment

 
_SUPORTE CLINICO PARA PACIENTES COM SUSPEITA DE MORTE ENCEFÁLICA - achei este pequeno artigo em português interessante e resolvi postar aqui
Picture
Picture
No manejo da morte encefálica, cada órgão precisa ser avaliado individualmente no sentido de se reduzir os danos já causados pela doença aguda do doador.
Picture
Monitorar a temperatura cerebral previne lesão secundária? E quando a temperatura cerebral persiste elevada a despeito das intervenções terapêuticas?
Picture
suporte_clnico_para_pacientes_crticos_em_risco_de_me.pdf
File Size: 257 kb
File Type: pdf
Download File

1 Comment

Evidence-based guideline update: Determining brain death in adults

11/22/2011

0 Comments

 
Guideline americano para morte encefálica
aanadultbraindeath.pdf
File Size: 298 kb
File Type: pdf
Download File

0 Comments

Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011

11/22/2011

0 Comments

 
Procurando por guidelines? Baixe agora esta recente publicação do CDC para prevenção de infeccções relacionada aos cateteres.

Para mais informações visite o site oficial do CDC - CLIQUE AQUI.

DICA PARA NOSSOS LEITORES:
MELHORE A  PRONÚNCIA E A COMPREENSÃO DO SEU INGLÊS MÉDICO OUVINDO OS  PODCASTS DO CDC
blood_stream_infection-guidelines-2011.pdf
File Size: 1064 kb
File Type: pdf
Download File

0 Comments

SURIVIVING SEPSIS CAMPAIGN

11/20/2011

1 Comment

 

Eli Lilly and Company  announced withdrawal of its Xigris® [drotrecogin alfa (activated)] product in all markets following results of the PROWESS-SHOCK study, which showed the study did not meet the primary endpoint of a statistically significant reduction in 28-day, all-cause mortality in patients with septic shock. The company is working with regulatory agencies on this withdrawal, and is in the process of notifying healthcare professionals and clinical trial investigators.

Physicians should not initiate treatment with Xigris in new patients and should stop ongoing treatment. The Society of Critical Care Medicine will keep the critical care community updated on this issue as appropriate.

More information for clinicians about the withdrawal of activated drotrecogin alfa is available on the European Medicines Agency and the U.S. Food and Drug Administration websites.



Adult
Update regarding rhAPC Recommendation in Surviving Sepsis Campaign Guidelines*

In response to the removal of Xigris® [drotrecogin alfa (activated)], also referred to as rhAPC, in all markets following results of the PROWESS-SHOCK study, the Surviving Sepsis Campaign withdraws its suggestions for use of rhAPC as stated in “Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock.” (1). The study did not meet the primary endpoint of a statistically significant reduction in 28-day, all-cause mortality in patients with septic shock.
Eli Lilly and Company, the maker of Xigris ®, is working with regulatory agencies on this withdrawal, and is in the process of notifying healthcare professionals and clinical trial investigators. According to their news release, physicians should not initiate treatment with Xigris in new patients and should stop ongoing treatment.

 1.  Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; [published correction appears in Crit Care Med 2008; 36:1394-1396] 36:296-327

*This revised recommendation was approved by the Surviving Sepsis Campaign Executive Committee and posted on the SSC website and list-serve on October 27, 2011. 

Items available below are provided with the intent that they can be printed from this website and used in hospitals across the world to improve patient care. Permission is not granted for commercial use, sales or other purposes not directly related to in hospital clinician education.

ssc_2008_guidelines.pdf
File Size: 723 kb
File Type: pdf
Download File

2008_ssc_pocket_guides.pdf
File Size: 103 kb
File Type: pdf
Download File

esicm_pocket_guide_2008_ssc_guidelines.pdf
File Size: 64 kb
File Type: pdf
Download File

Picture
CLIQUE NA IMAGEM ABAIXO  e conheça o site da campanha sobrevivendo à sepse:

Picture
1 Comment

    Autores

    Gerenciado por:

    Dr. Flavio Monteiro  de Oliveira Jr, Médico intensivista da USAN
    e
    Dr. Fernando Ramos Gonçalves, Enfermeiro intensivista da USAN.


    Arquivos

    July 2012
    June 2012
    February 2012
    January 2012
    November 2011
    September 2011
    August 2011
    July 2011

    Categorias

    All
    Airway Manegement
    Ards
    Artigos Comentados
    Cirurgia
    Clinical Trials
    Clube De Revista
    Critical Care Nutrition
    Cursos
    Educação Continuada
    Enfermagem
    Enfermeiros
    Farmacologia
    Ferramentas Uti
    Fisiologia
    Fisioterapia
    Fun
    Guidelines
    Links Enfermagem
    Links Medicos
    Medicina
    Medicina Intensiva
    Mensagem
    Monitorização
    Monitorização
    Motivação
    Noticias
    Papers Classicos
    Qualidade Em Uti
    Radiologia
    Reuniões Clínicas
    Sites Úteis
    Tecnologia
    Usan
    Ventilação Mecânica
    Video Aulas
    Videos
    Viedeo Aulas

    RSS Feed

    View my profile on LinkedIn
Powered by Create your own unique website with customizable templates.